SCHEMBL5337572

SCHEMBL5337572

Cc1cnc2cc(NS(=O)(=O)c3cccc(Cl)c3C)ccc2n1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.54
CCR4 P51679 3/20 0.49
SLC40A1 Q9NP59 1/20 0.49
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
EDNRB P24530 2/20 0.46
EDNRA P25101 2/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
THRB P10828 1/20 0.46
HPGD P15428 1/20 0.46
GSPT1 P15170 1/20 0.44
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
PTPN2 P17706 2/20 0.43
PTPN1 P18031 2/20 0.43
PTPN5 P54829 2/20 0.43
SGK1 O00141 1/20 0.42
NR1I2 O75469 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5343634 0.85 EDNRB (0.53) HSD11B1CCR4SLC40A1MEN1KMT2A
SCHEMBL5338606 0.85 HSD11B1 (0.55) HSD11B1CCR4SLC40A1MEN1KMT2A
SCHEMBL5343689 0.83 HSD11B1 (0.60) HSD11B1CCR4SLC40A1MEN1KMT2A
SCHEMBL5344543 0.81 HSD11B1 (0.50) HSD11B1CCR4SLC40A1MEN1KMT2A
SCHEMBL5342156 0.80 SLC40A1 (0.62) HSD11B1CCR4SLC40A1MEN1KMT2A
SCHEMBL614790 0.77 PKM (0.56) HSD11B1CCR4SLC40A1MEN1KMT2A
SCHEMBL616421 0.77 HSD11B1 (0.51) HSD11B1CCR4SLC40A1MEN1KMT2A
SCHEMBL617123 0.77 LMNA (0.62) HSD11B1CCR4MEN1KMT2AEDNRB
SCHEMBL10089752 0.77 PKM (0.68) HSD11B1SLC40A1MEN1KMT2AALDH1A1
SCHEMBL618236 0.77 PTPN1 (0.59) HSD11B1EDNRBEDNRAPTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 HSD11B1 6/4885CCR4 1963/4885SLC40A1 4120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.